2014

1. Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review

   International Journal of Oncology, Vol. 44, Núm. 1, pp. 5-16

2. Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: A medical chart review across ten centers in five European countries

   Cancer Medicine, Vol. 3, Núm. 6, pp. 1517-1526